Joseph Vacca

#BusDev Exec w/ 20 years of #Sales & #Marketing and #Management in #Biotech. Employed at Invicro, supporting preclin-late phase #imaging studies in #Onco & #CNS

[SNMMI @SNM_MI]

Time is running out! Maximize your gift by December 31!

We are working hard to reach our 2025 Annual Fund goal. Achieving this target is critical to ensuring continuous funding for groundbreaking research, essential education and professional development, and advocacy.

[New England Patriots @Patriots]

Is a new pair of headphones on your Black Friday shopping list!?

Repost to win a pair of Sony WH-1000XM6 noise canceling headphones: https://t.co/3GG8oQZiqf

[SNMMI @SNM_MI]

So happy that you were in attendance to share your perspective!

[SNMMI @SNM_MI]

Hearing from Jud, a patient who was diagnosed with neuroendoctine tumors, about his experience in the NETTR-2 trial and RLT therapy.

[Joseph Vacca @JosephVacca]

@CalaisJeremie @UCLA @UCLAHealth @UCLAJCCC @CzerninJohannes Congrats @CalaisJeremie - this is a major milestone

[JNM @JournalofNucMed]

Current capabilities and future prospects for dosimetry software for #theranostic applications: https://t.co/8jW5wpyUkz

#NuclearMedicine #RPTherapy @JuliaBroschLenz

[SNMMI @SNM_MI]

Help accelerate the cure and submit your abstract by January 13, 2025 at 11:59pm for a chance to present your innovative scientific investigations to a global audience of medical imaging professionals at the 2025 SNMMI Annual Meeting in New Orleans!

https://t.co/bKJcIJgC3O

[JNM @JournalofNucMed]

⁶⁸Ga-FAPI46 PET has potential as an effective imaging method for evaluating FAP expression in progressive fibrosis by #hypertension. https://t.co/XV2eFU8QIT

#NuclearMedicine #PETscan

[WMIS WIMIN @WIMIN_WMIS]

Meet Dr. Kelly Henry , our dedicated leader whose passion for fostering the next generation of scientists shines brightly. Kelly's unwavering commitment to supporting junior women in science and her invaluable contributions to the field make her a beacon of inspiration 🌟

[JNM @JournalofNucMed]

JNM Illustrated Post: First-in-human ²¹²Pb-PSMA–targeted α-therapy SPECT/CT imaging in a patient with metastatic castration-resistant prostate cancer. https://t.co/uyweOkuvw2

#NuclearMedicine #RPTherapy #ProstateCancer @DrDavePattison @AdvanCell_Iso

[Invicro @Invicro]

Join Beth Rodriguez tomorrow, February 13, at #SCOPE2024 for a lunch session that promises to reshape your approach to late-phase CNS and Oncology imaging trials, from unraveling imaging CROs to navigating processes for start-ups. #SCOPEsummit #imagingCRO

[Rep. Elise Stefanik @RepStefanik]

I will always deliver results. The resignation of Harvard’s antisemitic plagiarist president is long overdue. Claudine Gay’s morally bankrupt answers to my questions made history as the most viewed Congressional testimony in the history of the U.S. Congress. Her answers were absolutely pathetic and devoid of the moral leadership and academic integrity required of the President of @Harvard. This is just the beginning of what will be the greatest scandal of any college or university in history.

Our robust Congressional investigation will continue to move forward to expose the rot in our most “prestigious” higher education institutions and deliver accountability to the American people.

[Bill Ackman @BillAckman]

I am pro-Palestinian. Some might be surprised by this due to my recent advocacy on @X for Israel, but you shouldn’t be.

I am anti-terrorist, not anti-Palestinian. It is not inconsistent to be pro-Israel and pro-Palestinian. And my pro-Palestinian viewpoint is not a new one. My pro-Palestinian perspective began more than 30 years ago when I was introduced to the Palestinian community and their plight in the early 1990s.

I have invested millions in helping promote Palestinian economic development and peaceful coexistence. We would do a lot more if we could be confident that the funds would be used productively.

The crisis in Gaza is largely due to a failure of leadership. The Palestinians elected Hamas in 2006 after Israel withdrew and evicted 9,000 of its own citizens from their Gazan homes. Israel withdrew from Gaza for peace. It was a small scale test of a two-state solution.

Rather than building the Singapore of the Middle East over the last 18 years, Hamas diverted funding to build tunnels, rockets and munitions to wage terror and war in an effort to eliminate Israel and kill Jews.

Like the Israelis, the vast majority of Palestinians want peace. They want opportunities for employment so they can earn a living wage to support and educate their families so the next generation can build a better life.

They want peace, beauty, happiness, health and prosperity as we all do. All of that would have been possible with Gazan leadership which focused on economic development rather than terrorism. Israel and (most of) the world wanted the Gazan experiment to succeed.

Israel simply wanted peace. Israel built a fence and created checkpoints to protect its citizens from suicide bombers and other forms of terror. The Egyptians built a concrete wall at their border with Gaza for the same reasons. The need for a fence and checkpoints is made self-evident by the catastrophic impact on Israel when the fence was breached on Oct. 7th.

Hamas is in the business of terrorism. Hamas makes money with grift, corruption, and funding from Israel’s enemies who support Hamas to achieve their own anti-Israel objectives. Hamas and those that support it don’t care about the Palestinians. The Palestinians are simply a tool to implement their anti-Israel and/or anti-Jew objectives.

Like other businesses, Hamas has a corporate hierarchy where those at the top make thousands of times more than the ‘workers’ at the bottom. Hamas’ leaders have put aside hundreds of millions and even billions for themselves.

Hamas uses their ‘culture’ of terrorism, cash, and other incentives to motivate young, brainwashed —often from youth—, radicalised militants to implement death, torture and destruction. Their ‘success’ at terrorism attracts more funding, amplifies Israel’s response, and the cycle continues.

Hamas does not care about the Palestinian people. Hamas knew with certainty how Israel would respond to the torture, rape, beheading, and slaughter of Israeli women, children, seniors and infants on Oct. 7th.

Hamas’ plan was to hide out in their tunnels and headquarters built under major hospitals, limit evacuations so that Palestinian citizens are exposed to the inevitable Israeli military response, and then rally the world against Israel in a globally coordinated response as innocent civilians die.

Israel has no choice but to destroy Hamas. It cannot allow its survival, as Hamas’ existence remains an existential threat. If ISIS invaded our southern border, we would do the same. We would warn civilians to evacuate and then we would go in and destroy the terrorists. We wouldn’t cease fire until they were obliterated.

The whole situation is an incredible tragedy. While I have always hoped for a viable and peaceful two-state solution, the Gaza experiment has been an abject failure. Future efforts for statehood for the Palestinians must learn from this catastrophe.

As always, I welcome your input, critiques and rebuttal.

What did I get wrong?

[Invicro @Invicro]

Congrats to our New Haven team for stepping it up - surpassing fundraising goals and braving the weather at the Walk to End Alzheimer’s. It’s not too late to join our Boston walk team on Oct. 15: https://t.co/rzXRzi02D9

[Invicro @Invicro]

Discover our complete solutions including radiochemistry, preclinical research, dosimetry, clinical imaging core lab, image analysis and more: https://t.co/qwsql8YBbp

#radiopharmaceuticals #theranostics #oncology #radioligandtherapy #imagingCRO

[REALM IDx @REALMIDx]

There’s been a lot of excitement with the launch of REALM Pharma Services (RPS). Stay tuned as we show you how #REALM brings together Genomics, Imaging, Pathology and Informatics for the next phase of #precisionmedicine!
#integrateddiagnostics #pharmaservices #Ambry #Invicro

[Joseph Vacca @JosephVacca]

@m_wall Agreed

[Invicro @Invicro]

Watch experts from @Novartis, @FusionPharmaInc, RayzeBio & Invicro weigh in on the emerging field of #theranostics & the unique requirements for developing these therapies: https://t.co/KAycC2H9Bh

#radiopharmaceuticals #oncology #radioligandtherapy #imagingCRO

[Invicro @Invicro]

Radiochemistry support for alpha, beta & gamma emitting isotopes is one of the most crucial steps in developing & validating #radiopharmaceutical candidates. Discover our preclinical radiochemistry solutions: https://t.co/XdVMUJOJji

#theranostics #radioligandtherapy

[Joseph Vacca @JosephVacca]

We know the ins and outs of #radiopharmaceuticals and #nuclearmedicine - come chat with us at the booth or some to our annual shindig. #snmmi #snmmi2023 https://t.co/ExM70XFQ6j